SEOUL, South Korea
(BUSINESS WIRE) -- ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) application to initiate a Phase 2 clinical trial evaluating the safety and efficacy of IM-101, a novel complement C5 inhibitor, for the treatment of Myasthenia Gravis.

The forthcoming multicenter, randomized, double-blind, placebo-controlled study will enroll up to 90 patients to evaluate the effectiveness and safety of monthly IM-101 dosing in relieving complement-induced symptoms in MG.

“This IND approval is pivotal for us as it brings us one step closer to delivering a transformative therapy for patients with autoimmune disorders”, said Dr. Dongjo Kim, the CEO of ImmunAbs, “we believe IM-101 has the potential to deliver deeper therapeutic responses and more durable remissions in patients who have failed to achi ... Read more »

Ag leader strengthens workplace program that adds social services for thousands of farm workers.

(BUSINESS WIRE) -- Dole (NYSE: DOLE) today announced the signing of new public-private agreements to advance its award-winning Information and Wellbeing Centers (IWCs), a workplace-based initiative pioneered by Dole designed to deliver vital public and private services directly to the workplace, improving quality of life for agricultural workers in Costa Rica’s rural areas.

The announcement was made during the forum “Information and Wellbeing Centers: Public-Private Partnerships that Improve Lives,” hosted by Dole Fresh Fruit. During the event, Dole signed memorandums of understanding with two key national institutions—Caja Costarricense de Seguro Social (CCSS) and Banco Popular—further strengthening its commitment to inclusive development and equitable service access.

Launched in 2020, Dole’s IWC model has redefined how rural w ... Read more »

BELLEVUE, Neb. 
Learners will have access to Lenovo’s globally recognized supply chain expertise through real-world case studies and subject matter experts.
(BUSINESS WIRE) -- Lenovo, the global technology powerhouse, recognized in the top 10 in the Gartner Supply Chain Top 25, and Bellevue University, one of the nation’s top online universities, are teaming up to develop the next generation of supply chain professionals.

“We believe that bringing real-world Global Supply Chain experience and learning directly into an education curriculum is precisely the optimal way to upskill the workforce of the future,” said Ben Massie, Vice President, Global Supply Chain, Lenovo. “Teaming up with Bellevue allows us to attract the right talent using the right technology and deliver on our mission to make ‘smarter technology for all’ a reality.”

As a preferred higher education institution tapped to team up with Lenov ... Read more »

WILMINGTON, Del. - 
LYCRA® Brand and QIRA® are Principal Sponsors of the 2025 Copenhagen Edition

(BUSINESS WIRE)--The LYCRA Company, a global leader in developing sustainable fibers and solutions for the apparel industry, announced today that its CEO, Gary Smith, is a speaker at the Global Fashion Summit: Copenhagen Edition 2025. He will be joined on stage by Jon Veldhouse, CEO of Qore®, the maker of QIRA®, a next-generation BDO and a key ingredient in bio-derived LYCRA® fiber, which is launching later this year.

Smith and Veldhouse will discuss the development of this sustainable fiber made from annually renewable field corn during their Fireside Chat: From Farm to Fashion. Their session takes place on Wednesday, June 4, at 3:35 CEST in the DR Concert Hall. The discussion will be moderated by Amy Nguyen, a researcher, writer, and founder of Sustainable & Social.

This is the first time both companies are parti ... Read more »

NEW YORK - Monday, 02. June 2025 AETOSWire 

Vertically Integrated Plan includes Hydrometallurgical Refinery at Kahama

$2.37 Billion After-Tax NPV (8%) and 22.9% After-Tax IRR at $8.49 per Pound Nickel Price

Initial Assessment Proposes a 22-Year Mine Plan at Average 2.39% Nickel Equivalent Grade

Webcast with Technical Leadership Team at 10 AM ET on Tuesday, June 3, 2025

(BUSINESS WIRE) -- Lifezone Metals Limited’s (NYSE: LZM) Chief Executive Officer, Chris Showalter, and Chief Operating Officer, Gerick Mouton, announce today the results from the Initial Assessment for its flagship Kabanga Nickel Project in northwest Tanzania. The Initial Assessment evaluates a vertically integrated mining, processing and refining operation, commencing with a high-grade nickel sulfide underground mine and concentrator at the Kabanga site, followed five years later by a hydrometallurgical refinery at Kahama. The study covers the Main, MNB, Kima, ... Read more »

SAN CARLOS, Calif. - Monday, 02. June 2025

Preliminary results highlight anti-tumor activity and favorable safety profiles of both B7-H4-targeting ADC and CDK2 inhibitor

Data underscore strength of emerging breast cancer pipeline as part of BeOne’s global transformation with next wave of innovation

(BUSINESS WIRE) -- BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, announced new clinical data from its emerging breast cancer pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Poster presentations feature preliminary results of the dose escalation studies of two investigational molecules: BG-C9074, a novel B7-H4-targeting antibody-drug conjugate (ADC) in patients with advanced solid tumors, including breast cancer, and BG-68501, a cyclin-dependent kinase-2 inhibitor (CDK2i), in HR+/HER2- breast cancer patients with prior CDK4/6i exposure.

“Presenting the first ... Read more »

SAN CARLOS, Calif. - Monday, 02. June 2025 AETOSWire Print 

BRUKINSA plus venetoclax demonstrated high response rates and a favorable safety profile across CLL patient types in SEQUOIA Arm D, including those with high-risk del(17p) mutational status

At 5-year follow-up of SEQUOIA Arm C, BRUKINSA monotherapy showed sustained OS and PFS benefit in hard-to-treat del(17p) CLL patients versus historical data

(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today will present new data from the Arm C and D cohorts of the pivotal, global Phase 3 SEQUOIA trial of BRUKINSA® (zanubrutinib). The findings underscore the strong and consistent efficacy of BRUKINSA across CLL patient types, including high-risk mutation status. These data will be presented in two rapid oral presentations at the American Society of Clinica ... Read more »

PARK CITY, Utah - Monday, 02. June 2025 AETOSWire 

(BUSINESS WIRE) -- iFIT Inc., a global leader in connected fitness and interactive content, today announced the expansion of its iFIT AI Coach (beta) across 19 countries: Australia, Austria, Belgium, Canada, Finland, France, Germany, Ireland, Italy, Luxembourg, Mexico, Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland, and the UK. This strategic expansion brings iFIT’s intelligent, personalized fitness technology to more athletes around the globe.

AI Coach is iFIT’s most advanced digital training tool to date, leveraging proprietary technology and user data to deliver hyper-personalized fitness and wellness plans. The tool adapts dynamically to users' goals, schedules, and performance, offering real-time feedback and motivation across a wide range of fitness categories—from strength and cardio to recovery and mindfulness.

“Expanding iFIT AI Coach beyond th ... Read more »

(BUSINESS WIRE)--12BET, a pioneering name in the igaming world since 2007, is honored to be shortlisted in two categories at the 2025 EGR Marketing & Innovation Awards: Sportsbook Marketing Campaign, and Marketing Team of the Year – B2C. This recognition highlights the brand’s ongoing dedication to creating meaningful and original experiences that resonate with sports audiences and digital communities.

The EGR Marketing & Innovation Awards are among the most respected accolades in the online gaming industry. Held annually, the awards celebrate creativity, strategic thinking, and innovation across the sector, attracting participation from many of the world’s leading companies. For 12BET, being named a finalist is a meaningful milestone that showcases the brand’s energy, originality, and deep-rooted passion for sports culture.

12BET’s approach to creativity is rooted in connection. From immersive storytelling to interactive challen ... Read more »

NEWARK, Calif. & OSAKA, Japan & CAMBRIDGE, Mass. - Monday, 02. June 2025

Rusfertide plus current standard of care more than doubled clinical response rates across high- and low-risk PV groups, significantly reducing phlebotomy eligibility compared to placebo plus current standard of care, which was the primary endpoint
All key secondary endpoints met with statistical significance, including a nearly three-fold reduction in the proportion of patients requiring phlebotomy and a four-fold improvement in hematocrit control in rusfertide arm compared to placebo arm, as well as improvements in patient-reported outcomes
No serious adverse events considered related to rusfertide were reported
Rusfertide has received Orphan Drug designation and Fast Track designation from the U.S. FDA
 

(BUSINESS WIRE)--Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announced detailed results from th ... Read more »

• The TOURISE Awards spotlight the world’s most impactful destinations, celebrating culture, connection, and innovation in travel.
• Five categories are open for nominations, with a flagship award selected by an independent jury of global tourism experts.
• Nominations are open until July 9 and winners will be honored at the TOURISE Summit in Riyadh, taking place from November 11–13, 2025.

The TOURISE Awards officially launched today as a new global benchmark celebrating excellence in tourism destinations. Created to honor places that are shaping the future of travel, the Awards spotlight destinations delivering meaningful, memorable, and measurable value across the traveler journey. Nominations are now open to individual travelers, industry professionals, and organizations passionate about recognizing the world’s most exceptional places.

The TOURISE Awards are an extension of the TOURISE pla ... Read more »

Abu Dhabi, United Arab Emirates 
MAG Group Holding, the diversified, multinational real estate development company, officially launched Riviera Heights, the highly anticipated first luxury residential development in Marsa Zayed, Jordan’s largest mixed-use beach front community.

Riviera Heights is the first project in a plan to transform a 320-hectare section of Jordan’s Red Sea coast into an international tourism and residential destination.

Riviera Heights will consist of four, 35-story luxury apartment buildings, spread over 51,000  m2, located on the southern edge of the Marsa Zayed development area. The development will include more than 1,250 seafront apartments.

Moafaq A. Al Gaddah, Founder and Chairman of MAG Group Holding, said: “Riviera Heights captures the true essence of Jordan—its warmth, heritage, and culture. We are breathing new life and economic vitality into Aqaba by creating vibrant spaces that foster ... Read more »